Satisfaction and experiences of patients taking fingolimod and involved in a pharmacy-based patient support program in Switzerland — a qualitative study

Satisfaction and experiences of patients taking fingolimod and involved in a pharmacy-based patient support program in Switzerland — a qualitative study

Abstract Background Fingolimod is an oral multiple sclerosis drug that is considered a specialty drug due to its high cost and safety issues. The Fingolimod Patient Support Program (F-PSP) is a specialty pharmacy service developed to ensure the responsible use of fingolimod by promoting patient safe...

Full description

Bibliographic Details
Main Authors: Aline Bourdin, Julie Dubois, Rose-Anna Foley, Myriam Schluep, Olivier Bugnon, Jérôme Berger
Format: Article
Language:English
Published: BMC 2020-05-01
Series:BMC Health Services Research
Subjects:
Fingolimod
Multiple sclerosis
Patient support program
Specialty pharmacy service
Patient perceptions
Patient satisfaction
Online Access:http://link.springer.com/article/10.1186/s12913-020-05278-3

Internet

http://link.springer.com/article/10.1186/s12913-020-05278-3

Similar Items